帕金森病患者和临床医生对认知障碍的印象。
Patient and Clinician Impressions of Cognitive Impairment in Parkinson's Disease.
机构信息
Department of Medicine, University of Massachusetts Medical School, Worcester, MA, USA.
Department of Neurology, University of Massachusetts Medical School, Worcester, MA, USA.
出版信息
J Parkinsons Dis. 2020;10(4):1695-1698. doi: 10.3233/JPD-202110.
We investigated patient and clinician impressions of cognitive impairment and whether they correlated with objective measures of cognitive impairment. Cognitive categorization, neuropsychological assessment scores, and Montreal Cognitive Assessment scores were documented at baseline, 3 years, and 7 years for 388 PD patients in the Parkinson's Progression Markers Initiative (PPMI). We found that both patient and clinician impressions of cognitive decline were significantly associated with gold-standard criteria for cognitive impairment to a similar degree. Both patient and clinician perspectives should be considered in determining cognitive status and should be followed up with diagnostic testing.
我们调查了患者和临床医生对认知障碍的印象，以及这些印象是否与认知障碍的客观测量结果相关。在帕金森病进展标志物倡议（PPMI）中，我们对 388 名 PD 患者进行了认知分类、神经心理学评估分数和蒙特利尔认知评估分数的基线、3 年和 7 年的记录。我们发现，患者和临床医生对认知能力下降的印象与认知障碍的金标准标准显著相关，程度相似。在确定认知状态时，应同时考虑患者和临床医生的观点，并进行诊断性测试。
Zotero 插件